185 related articles for article (PubMed ID: 28108225)
1. Female schizophrenia patients and risk of breast cancer: A population-based cohort study.
Wu Chou AI; Wang YC; Lin CL; Kao CH
Schizophr Res; 2017 Oct; 188():165-171. PubMed ID: 28108225
[TBL] [Abstract][Full Text] [Related]
2. Survival analysis of the use of first and second generation antipsychotics among patients suffering schizophrenia: A nationwide population-based cohort study.
Chen VC; Liao YT; Lai TJ; Lane HY; Shao WC; Dewey M; Lee CT; Lu ML
Schizophr Res; 2015 Dec; 169(1-3):406-411. PubMed ID: 26481616
[TBL] [Abstract][Full Text] [Related]
3. Associations among antipsychotics, metabolism-related diseases, and cataracts in patients with schizophrenia: A retrospective cohort study.
Fang SC; Huang CY; Liao DL; Hsu CC; Shao YJ
Schizophr Res; 2019 Oct; 212():150-156. PubMed ID: 31395489
[TBL] [Abstract][Full Text] [Related]
4. Comparative risk of seizure with use of first- and second-generation antipsychotics in patients with schizophrenia and mood disorders.
Wu CS; Wang SC; Yeh IJ; Liu SK
J Clin Psychiatry; 2016 May; 77(5):e573-9. PubMed ID: 27249081
[TBL] [Abstract][Full Text] [Related]
5. Association between long-term use of prolactin-elevating antipsychotics in women and the risk of breast cancer: What are the clinical implications?
Hope JD; Keks NA; Copolov DL
Australas Psychiatry; 2023 Apr; 31(2):205-208. PubMed ID: 36927059
[TBL] [Abstract][Full Text] [Related]
6. Increased risk of dementia in patients with Schizophrenia: A population-based cohort study in Taiwan.
Lin CE; Chung CH; Chen LF; Chi MJ
Eur Psychiatry; 2018 Sep; 53():7-16. PubMed ID: 29859379
[TBL] [Abstract][Full Text] [Related]
7. Use of first- and second-generation antipsychotic medications in older patients with schizophrenia in Asia (2001-2009).
Xiang YT; Kreyenbuhl J; Dickerson FB; Ungvari GS; Wang CY; Si TM; Lee EH; He YL; Chiu HF; Yang SY; Chong MY; Tan CH; Kua EH; Fujii S; Sim K; Yong MK; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N; Shinfuku N
Aust N Z J Psychiatry; 2012 Dec; 46(12):1159-64. PubMed ID: 22790175
[TBL] [Abstract][Full Text] [Related]
8. Second-generation antipsychotic medications and risk of chronic kidney disease in schizophrenia: population-based nested case-control study.
Wang HY; Huang CL; Feng IJ; Tsuang HC
BMJ Open; 2018 May; 8(5):e019868. PubMed ID: 29794090
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic drug use and the risk of seizures: follow-up study with a nested case-control analysis.
Bloechliger M; Rüegg S; Jick SS; Meier CR; Bodmer M
CNS Drugs; 2015 Jul; 29(7):591-603. PubMed ID: 26242478
[TBL] [Abstract][Full Text] [Related]
10. Change in antipsychotic usage pattern and risk of relapse in older patients with schizophrenia.
Talaslahti T; Alanen HM; Hakko H; Isohanni M; Häkkinen U; Leinonen E
Int J Geriatr Psychiatry; 2013 Dec; 28(12):1305-11. PubMed ID: 23558986
[TBL] [Abstract][Full Text] [Related]
11. Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs: An Observational Study of US Women (Ages 18-64 Years).
Rahman T; Sahrmann JM; Olsen MA; Nickel KB; Miller JP; Ma C; Grucza RA
J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):7-16. PubMed ID: 34864772
[TBL] [Abstract][Full Text] [Related]
12. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
13. Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services.
Van Dorn RA; Andel R; Boaz TL; Desmarais SL; Chandler K; Becker MA; Howe A
J Clin Psychiatry; 2011 Apr; 72(4):502-8. PubMed ID: 21527125
[TBL] [Abstract][Full Text] [Related]
14. Socioeconomic factors influencing antipsychotic prescription for schizophrenia inpatients in China: a cross-sectional study.
Xue Q; Xiong X; Feng Y; Yao L; Chen S; Xiang L
Int Clin Psychopharmacol; 2014 Sep; 29(5):288-95. PubMed ID: 24323200
[TBL] [Abstract][Full Text] [Related]
15. Use of antipsychotics and risk of cerebrovascular events in schizophrenic patients: a nested case-control study.
Hsieh PH; Hsiao FY; Gau SS; Gau CS
J Clin Psychopharmacol; 2013 Jun; 33(3):299-305. PubMed ID: 23609396
[TBL] [Abstract][Full Text] [Related]
16. Weight gain on antipsychotic medication is associated with sustained use among veterans with schizophrenia.
Monnelly EP; Fonda J; Gagnon DR; Chittamooru S; Lawler EV
J Clin Psychopharmacol; 2015 Feb; 35(1):57-62. PubMed ID: 25514067
[TBL] [Abstract][Full Text] [Related]
17. Risk of extrapyramidal syndrome in schizophrenic patients treated with antipsychotics: a population-based study.
Yang SY; Kao Yang YH; Chong MY; Yang YH; Chang WH; Lai CS
Clin Pharmacol Ther; 2007 Apr; 81(4):586-94. PubMed ID: 17235331
[TBL] [Abstract][Full Text] [Related]
18. Association between second-generation antipsychotic medication half-life and hospitalization in the community treatment of adult schizophrenia.
Broder MS; Bates JA; Jing Y; Hebden T; Forbes RA; Chang E
J Med Econ; 2012; 15(1):105-11. PubMed ID: 21991926
[TBL] [Abstract][Full Text] [Related]
19. 'Real world' comparison of first- and second-generation antipsychotics in regard to length of inpatient hospitalization and number of re-hospitalizations.
Advokat C; Hill BD; Comaty JE
Psychiatr Q; 2008 Mar; 79(1):55-64. PubMed ID: 18060498
[TBL] [Abstract][Full Text] [Related]
20. Paliperidone is associated with reduced risk of severe hepatic outcome in patients with schizophrenia and viral hepatitis: A nationwide population-based cohort study.
Chang CH; Lane HY; Liu CY; Chen SJ; Lin CH
Psychiatry Res; 2019 Nov; 281():112597. PubMed ID: 31629300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
